Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Shares outstanding
- 29,463,330
- Total 13F shares
- 3,236,349
- Share change
- +93,778
- Total reported value
- $34,047,000
- Price per share
- $10.52
- Number of holders
- 13
- Value change
- +$1,027,245
- Number of buys
- 8
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
4.1%
|
1,200,000
|
$11,964,000 | — | 30 Sep 2017 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.4%
|
700,000
|
$6,979,000 | — | 30 Sep 2017 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
300,000
|
$2,991,000 | — | 30 Sep 2017 | |
| Knoll Capital Management, LLC |
13F
|
Company |
1%
|
300,000
|
$2,991,000 | — | 30 Sep 2017 | |
| Tourbillon Capital Partners, L.P. |
13F
|
Company |
0.85%
|
250,000
|
$2,493,000 | — | 30 Sep 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.68%
|
200,000
|
$1,994,000 | — | 30 Sep 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.34%
|
100,000
|
$997,000 | — | 30 Sep 2017 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
53,558
|
$534,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
19,800
|
$197,000 | — | 30 Sep 2017 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.05%
|
13,786
|
$137,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,562
|
$26,000 | — | 30 Sep 2017 | |
| FNY Managed Accounts LLC |
13F
|
Company |
0.01%
|
2,400
|
$23,000 | — | 30 Sep 2017 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
465
|
$5,000 | — | 30 Sep 2017 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) as of Q4 2017
As of 31 Dec 2017,
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,236,349 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, Knoll Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Tourbillon Capital Partners, L.P., BAKER BROS. ADVISORS LP, Artal Group S.A., Vanguard Group Inc, MILLENNIUM MANAGEMENT LLC, and GOLDMAN SACHS GROUP INC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
13
Q4 2017 holders
13
Holder diff
0
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.